The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 27, 2012

Filed:

Jun. 05, 2006
Applicants:

Michael Serrano-wu, Belmont, MA (US);

Makonen Belema, North Haven, CT (US);

Lawrence B. Snyder, Killingworth, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Denis R. St. Laurent, Newington, CT (US);

Ramesh Kakarla, South Glastonbury, CT (US);

Van N. Nguyen, New Britain, CT (US);

Yuping Qiu, Glastonbury, CT (US);

Xuejie Yang, Cheshire, CT (US);

John E. Leet, Madison, CT (US);

Min Gao, Madison, CT (US);

Donald R. O'boyle, Ii, Killingworth, CT (US);

Julie A. Lemm, Durham, CT (US);

Fukang Yang, Madison, CT (US);

Inventors:

Michael Serrano-Wu, Belmont, MA (US);

Makonen Belema, North Haven, CT (US);

Lawrence B. Snyder, Killingworth, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Denis R. St. Laurent, Newington, CT (US);

Ramesh Kakarla, South Glastonbury, CT (US);

Van N. Nguyen, New Britain, CT (US);

Yuping Qiu, Glastonbury, CT (US);

Xuejie Yang, Cheshire, CT (US);

John E. Leet, Madison, CT (US);

Min Gao, Madison, CT (US);

Donald R. O'Boyle, II, Killingworth, CT (US);

Julie A. Lemm, Durham, CT (US);

Fukang Yang, Madison, CT (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61K 31/4439 (2006.01); A61K 31/42 (2006.01); A61K 31/416 (2006.01); A61K 31/4025 (2006.01); C07D 413/14 (2006.01); C07D 403/14 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds having the structure of formula I are described. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular can inhibit the function of the HCV NS5A protein.


Find Patent Forward Citations

Loading…